Enter your terms above and click the 'Search' button.

Showing articles 0 to 11 of 11 Filter Applied: patent foramen ovale,medical treatment (Click to remove) Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke NEJM 384:970-971, , 2021 Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention Neurol 94:876-885, Messe, S.R.,et al, 2020 Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke? BMJ 362:k2515, Kuijpers, T.,et al, 2018 Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017 Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017 Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke NEJM 377:1033-1042,1006,1093, Sondergaard, L.,et al, 2017 Closure Versus Medical Therapy for Preventing Recurrent Stroke in Patients with Patent Foramen Ovale and a History of Cryptogenic Stroke or Transient Ischemic Attack Stroke 47:e188-e189, Li, J.,et al, 2016 Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013 Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism NEJM 368:1083-1091,1152, Meier, B.,et al, 2013 An Index to Identify Stroke-Related vs Incidental Patent Foramen Ovale in Cryptogenic Stroke Neurol 81:619-625,619, Kent, D.M.,et al, 2013 Patent Foramen Ovale Closure and Medical Treatments for Secondary Stroke Prevention Stroke 43:422-431, Kitsios,G.D.,et al, 2012 Showing articles 0 to 11 of 11